MYGN Q4 2020 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$487M

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

$0

Net Income

$0

EPS (Diluted)

$-0.59

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$20M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$539M

Stockholders' Equity

$880M

Cash & Equivalents

$117M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$195M	-100.0%
Gross Profit	$0	$146M	-100.0%
Operating Income	$0	-$9M	+100.0%
Net Income	$0	-$8M	+100.0%